Reviva Pharmaceuticals Holdings, Inc.RVPHNASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank100
3Y CAGR+267.3%
Studio
Year-over-Year Change

Price-to-book ratio

3Y CAGR
+267.3%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
49.6x
Strong expansion
Streak
3 yr
Consecutive growthElevated
PeriodValueYoY Change
202473.84+244.5%
202321.43+116.9%
20229.88+563.1%
20211.49-69.6%
20204.90+214.0%
2019-4.30-
20180.00-